دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Coronary Wave Intensity Analysis as an Invasive and Vessel-Specific Index of Myocardial Viability.
Ryan, Matthew PhD; De Silva, Kalpa PhD; Morgan, Holly MBBS; O'Gallagher, Kevin PhD; Demir, Ozan M. MBBS; Rahman, Haseeb PhD; Ellis, Howard BSc; Dancy, Luke PhD; Sado, Daniel MD; Strange, Julian MD; Melikian, Narbeh MD; Marber, Michael PhD; Shah, Ajay M. MD; Chiribiri, Amedeo PhD; Perera, Divaka MD
doi : 10.1161/CIRCINTERVENTIONS.122.012394
Coronary angiography and viability testing are the cornerstones of diagnosing and managing ischemic cardiomyopathy. At present, no single test serves both needs.
Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction.
Choo, Eun Ho MD; Choi, Ik Jun MD; Lim, Sungmin MD; Moon, Donggyu MD; Kim, Chan Joon MD; Park, Mahn-Won MD; Kim, Min Chul MD; Hwang, Byung-Hee MD; Lee, Kwan Yong MD; Seok Choi, Yun MD; Kim, Hee-Yeol MD; Yoo, Ki-Dong MD; Jeon, Doo Soo MD; Ahn, Youngkeun MD; Chang, Kiyuk MD; TALOS-AMI Investigators
doi : 10.1161/CIRCINTERVENTIONS.122.012157
Data regarding prognosis and management after nuisance bleeding (NB) is limited. The purpose was to examine the prognostic significance of NB in patients receiving potent dual antiplatelet treatment (DAPT) after acute myocardial infarction and the impact of de-escalation of DAPT on clinical outcomes thereafter.
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation.
Costa, Giuliano MD; Pilgrim, Thomas MD; Amat Santos, Ignacio J. MD; De Backer, Ole MD; Kim, Won-Keun MD; Barbosa Ribeiro, Henrique MD; Saia, Francesco MD; Bunc, Matjaz MD; Tchetche, Didier MD; Garot, Philippe MD; Ribichini, Flavio Luciano MD; Mylotte, Dzxcfewarren MD; Burzotta, Francesco MD; Watanabe, Yusuke MD; De Marco, Federico MD; Tesorio, Tullio MD; Rheude, Tobias MD; Tocci, Marco MD; Franzone, Anna MD; Valvo, Roberto MD; Savontaus, Mikko MD; Wienemann, Hendrik MD; Porto, Italo MD; Gandolfo, Caterina MD; Iadanza, Alessandro MD; Bortone, Alessandro Santo MD, PhD; Mach, Markus MD; Latib, Azeem MD; Biasco, Luigi MD; Taramasso, Maurizio MD; Zimarino, Marco MD; Tomii, Daijiro MD; Nuyens, Philippe MD; Sondergaard, Lars PhD; Camara, Sergio F. MD; Palmerini, Tullio MD; Orzalkiewicz, Mateusz MD; Steblovnik, Klemen MD; Degrelle, Bastien MD; Gautier, Alexandre MD; Del Sole, Paolo Alberto MD; Mainardi, Andrea MD; Pighi, Michele MD; Lunardi, Mattia MD, MSc; Kawashima, Hideyuki MD; Criscione, Enrico MD; Cesario, Vincenzo MD; Biancari, Fausto MD; Zanin, Federico MD; Joner, Michael MD; Esposito, Giovanni MD; Adam, Matti MD; Grube, Eberhard PhD; Baldus, Stephan MD; De Marzo, Vincenzo MD; Piredda, Elisa MD; Cannata, Stefano MD; Iacovelli, Fortunato MD; Andreas, Martin MD; Frittitta, Valentina MD; Dipietro, Elena MD; Reddavid, Claudia MD; Strazzieri, Orazio MD; Motta, Silvia MD; Angellotti, Domenico MD; Sgroi, Carmelo MD; Kargoli, Faraj MD; Tamburino, Corrado MD, PhD; Barbanti, Marco MD; for the REVASC-TAVI Registry
doi : 10.1161/CIRCINTERVENTIONS.122.012417
The best management of stable coronary artery disease (CAD) in patients undergoing transcatheter aortic valve implantation (TAVI) is still unclear due to the marked inconsistency of the available evidence.
When Fixing Hinders, Why We Should Sometimes Fight the Urge to Fix.
Ibrahim, Homam MD; Williams, Mathew R. MD
Rehospitalization Events After Aortic Valve Replacement: Insights From the PARTNER Trial.
Huded, Chetan P. MD MSc; Arnold, Suzanne V. MD, MHA; Chhatriwalla, Adnan K. MD; Saxon, John T. MD; Kapadia, Samir MD; Yu, Xiao PhD; Webb, John G. MD; Thourani, Vinod H. MD; Kodali, Susheel K. MD; Smith, Craig R. MD; Mack, Michael J. MD; Leon, Martin B. MD; Cohen, David J. MD, MSc
doi : 10.1161/CIRCINTERVENTIONS.122.012195
Rehospitalization is a common end point in clinical trials of structural heart interventions, but whether rehospitalization is clinically and prognostically relevant in these patients is uncertain.
Trial End Points and Measures of Quality: Similar but Different.
Nathan, Ashwin S. MD, MS; Fiorilli, Paul N. MD; Giri, Jay MD, MPH
Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study.
Costa, Giuliano MD; Barbanti, Marco MB; Rosato, Stefano MSc; Seccareccia, Fulvia MSc; Tarantini, Giuseppe MD, PhD; Fineschi, Massimo MD; Salizzoni, Stefano MD; Valvo, Roberto MD; Tamburino, Corrado MD, PhD; Biancari, Fausto MD; Baglio, Giovanni MD; Santoro, Gennaro MD; Baiocchi, Massimo MD; D'Errigo, Paola MSc; the OBSERVANT II Research Group
doi : 10.1161/CIRCINTERVENTIONS.122.012294
Head-to-head comparisons of devices for transcatheter aortic valve implantation (TAVI) are mostly limited to 2-arm studies so far. The aim of this study was to compare simultaneously outcomes of the most used, second- and third-generation transcatheter aortic valves in a real-world population.
Advancing Transcatheter Aortic Valve Replacement to the Frontiers of Lifetime Valve Management: Deliberations From the OBSERVANT II Trial.
Tully, Andrew MD; Tom, Stephanie MD; Crepy D'Orleans, Charles BA; Grubb, Kendra J. MD, MHA
Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry.
Sandhu, Amneet MD, MSc; Varosy, Paul D. MD; Du, Chengan PhD; Aleong, Ryan G. MD; Tumolo, Alexis Z. MD; West, J. Jason MD; Tzou, Wendy S. MD; Curtis, Jeptha P. MD; Freeman, James V. MD, MPH; Friedman, Daniel J. MD; Hess, Paul L. MD, MHS
doi : 10.1161/CIRCINTERVENTIONS.122.012183
Left atrial appendage occlusion is an important alternative to anticoagulation in select patients with nonvalvular atrial fibrillation. Trends in real-world device sizing and associated short-term complications have not been characterized.
Native and Post-Repair Residual Mitral Valve Prolapse Increases Forces Exerted on the Papillary Muscles: A Possible Mechanism for Localized Fibrosis?.
Park, Matthew H. MS ,,*; van Kampen, Antonia MD ,,,*; Melnitchouk, Serguei MD, MPH; Wilkerson, Robert J. BS; Nagata, Yasufumi MD, PhD; Zhu, Yuanjia MD, MS; Wang, Hanjay MD; Pandya, Pearly K. MS; Morningstar, Jordan E. BS; Borger, Michael A. MD, PhD; Levine, Robert A. MD; Woo, Y. Joseph MD
doi : 10.1161/CIRCINTERVENTIONS.122.011928
Recent studies have linked mitral valve prolapse to localized myocardial fibrosis, ventricular arrhythmia, and even sudden cardiac death independent of mitral regurgitation or hemodynamic dysfunction.
